📑Disc. ant. vancomicina, Disc. ant. ampicilina, Disc. ant. nitrofuranto, Disc. ant. norfloxacina, Disc. ant. trimetoprina, Disc. ant. cefradina, Chocolate II Agar (placa), frasco p/ hemocultivo
Procurement process summary
This process is to purchase Disc. ant. vancomicina, Disc. ant. ampicilina, Disc. ant. nitrofuranto, Disc. ant. norfloxacina, Disc. ant. trimetoprina, Disc. ant. cefradina, Chocolate II Agar (placa), frasco p/ hemocultivo.
This contract was awarded by 🇺🇾 NO VIGENTE Instituto Nacional del Cáncer for an amount of UYU 101,440 to 1 supplier. It was published on 2002-10-03 through not reported
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 NO VIGENTE Instituto Nacional del Cáncer Buying unitnot reported Publication date2002-10-03 Contest statusnot reported DescriptionR/211073190010Awards
This award was granted to RELAB S.R.L. by NO VIGENTE Instituto Nacional del Cáncer for an amount of UYU 101,440. The procurement process was conducted through Not available for the category of Not available. The award was granted on 2002-04-10.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 RELAB S.R.L. | UYU 101,440 | 2002-04-10 |
Market context and opportunities
The execution of this contract allows the entity NO VIGENTE Instituto Nacional del Cáncer to fulfill its public service objectives efficiently.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-a13962-R-211073190010Publication date2002-10-03Contract datenot reportedAward date2002-04-10Categoriesnot reportedPurchase modalitynot reportedMethod detailsnot reportedStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
